Tetradecanoylphorbol Acetate: Clinical Trials

2 trials of Tetradecanoylphorbol Acetate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1

Follow Tetradecanoylphorbol Acetate: new trials by email Literature Review of Tetradecanoylphorbol Acetate trials Research Report on Tetradecanoylphorbol Acetate

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection
alteplase (recombinant t-PA), Heparin - Central Venous Catheter Thrombosis, Central Venous Catheter Associated Bloodstream Infection
Phase 2CompletedMedical College of Wisconsin202019-04-222021-07-13
Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies
12-O-tetradecanoylphorbol-13-acetate, Dexamethasone, Choline magnesium trisalicylate - Leukemia
Phase 2TerminatedRutgers, The State University of New Jersey12011-03-012015-11-04

Conditions studied

Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Upper Extremity Deep Vein Thrombosis (1)

Sponsors

Medical College of Wisconsin (1)  ·  Rutgers, The State University of New Jersey (1)

Countries

United States (2)

Top investigators

Roger Strair, MD, PhD (1)

NIH funding

P30CA068485 (1), P30CA072720 (1)